Target intelligence / Profile preview

Pancreatic progenitor cell differentiation and proliferation factor-like protein (PPDPFL)

Target
PPDPFL
Molecular classification
Other (protein-coding gene; not a known enzyme, receptor, channel, transporter, or transcription factor)
01

Overview

Pancreatic progenitor cell differentiation and proliferation factor-like protein is a broadly expressed protein-coding gene involved in cell differentiation, notably during pancreatic lineage specification. Although its name suggests a critical role in pancreatic progenitor formation and proliferative regulation, functional studies in human stem cell models and fetal pancreas tissue have shown that PPDPFL is dispensable for proper pancreas development. Its expression is widespread in both fetal and adult pancreatic cells and is regulated by generic endodermal transcription factors (FOXA1/2, SOX9) rather than pancreas-specific factors. In cancer biology, PPDPFL has been associated with increased tumor progression and poorer prognosis in several cancer types, particularly hepatocellular carcinoma, though its direct functional contribution is not established. No known drugs directly target this gene, and no established mechanisms of action or safety issues have been reported. PPDPFL may have value as a prognostic biomarker in selected cancers, but its relevance as a true therapeutic target is currently unproven.

Other names
C8orf22Chromosome 8 open reading frame 22Exocrine differentiation and proliferation factor-like proteinPancreatic progenitor cell differentiation and proliferation factor-like proteinPPDPFL
02

Biological functions

Cell differentiation (predicted, based on genome resource annotations and its zebrafish ortholog)Subtle regulatory roles in pancreatic lineage developmentPossible protein regulatory roles in tumorigenesis and proliferation (mainly inferred from cancer studies, not proven direct biological function)
03

Disease associations

Cancer (reported as pro-tumorigenic in non-small cell lung cancer, ovarian cancer, colorectal cancer, pancreatic ductal adenocarcinoma, and hepatocellular carcinoma)Unknown/Other (suggested but not confirmed role in normal pancreas developmental disorders)
04

Biomarkers

PPDPFL expression as a prognostic marker in hepatocellular carcinomaPart of multi-gene marker panels in prostate cancer recurrence risk

Beyond the preview

Go deeper on Pancreatic progenitor cell differentiation and proliferation factor-like protein (PPDPFL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pancreatic progenitor cell differentiation and proliferation factor-like protein (PPDPFL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call